Randomized Exploratory Clinical Trial to Evaluate the Safety and Effectiveness of Stem Cell Product in Alcoholic Liver Cirrhosis Patient.
Phase of Trial: Phase II
Latest Information Update: 22 Mar 2016
At a glance
- Drugs Mesenchymal stem cell therapy (Primary)
- Indications Alcoholic cirrhosis
- Focus Therapeutic Use
- Sponsors Pharmicell
- 16 Mar 2016 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 20 Feb 2016 New trial record